367 related articles for article (PubMed ID: 7476926)
1. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
Johansen TH; Chaudhary A; Verdoorn TA
Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
[TBL] [Abstract][Full Text] [Related]
2. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
Donevan SD; Rogawski MA
Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
[TBL] [Abstract][Full Text] [Related]
3. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
Partin KM; Mayer ML
Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699
[TBL] [Abstract][Full Text] [Related]
4. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
Yamada KA; Turetsky DM
Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
[TBL] [Abstract][Full Text] [Related]
5. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones.
Rammes G; Swandulla D; Spielmanns P; Parsons CG
Neuropharmacology; 1998; 37(10-11):1299-320. PubMed ID: 9849667
[TBL] [Abstract][Full Text] [Related]
6. Modulation of desensitization at glutamate receptors in isolated crucian carp horizontal cells by concanavalin A, cyclothiazide, aniracetam and PEPA.
Shen Y; Lu T; Yang XL
Neuroscience; 1999 Mar; 89(3):979-90. PubMed ID: 10199629
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
Kessler M; Arai A; Quan A; Lynch G
Mol Pharmacol; 1996 Jan; 49(1):123-31. PubMed ID: 8569697
[TBL] [Abstract][Full Text] [Related]
8. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices.
Rammes G; Swandulla D; Collingridge GL; Hartmann S; Parsons CG
Br J Pharmacol; 1996 Mar; 117(6):1209-21. PubMed ID: 8882618
[TBL] [Abstract][Full Text] [Related]
9. Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes.
Sharp RL; May PC; Mayne NG; Snyder YM; Burnett JP
Eur J Pharmacol; 1994 Jan; 266(1):R1-2. PubMed ID: 7511109
[TBL] [Abstract][Full Text] [Related]
10. Interactions of allosteric modulators of AMPA/kainate receptors on spreading depression in the chicken retina.
Kertész S; Kapus G; Lévay G
Brain Res; 2004 Oct; 1025(1-2):123-9. PubMed ID: 15464752
[TBL] [Abstract][Full Text] [Related]
11. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
Donevan SD; Yamaguchi S; Rogawski MA
J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
[TBL] [Abstract][Full Text] [Related]
12. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
Desai MA; Burnett JP; Ornstein PL; Schoepp DD
J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
[TBL] [Abstract][Full Text] [Related]
13. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.
Arai AC; Kessler M; Rogers G; Lynch G
Mol Pharmacol; 2000 Oct; 58(4):802-13. PubMed ID: 10999951
[TBL] [Abstract][Full Text] [Related]
14. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
Partin KM; Patneau DK; Mayer ML
Mol Pharmacol; 1994 Jul; 46(1):129-38. PubMed ID: 8058047
[TBL] [Abstract][Full Text] [Related]
15. Characterization of AMPA receptors on isolated amacrine-like cells in carp retina.
Shen Y; Zhou Y; Yang XL
Eur J Neurosci; 1999 Dec; 11(12):4233-40. PubMed ID: 10594649
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors.
Wong LA; Mayer ML
Mol Pharmacol; 1993 Sep; 44(3):504-10. PubMed ID: 7690448
[TBL] [Abstract][Full Text] [Related]
18. Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices.
Cowen MS; Beart PM
Br J Pharmacol; 1998 Feb; 123(3):473-80. PubMed ID: 9504388
[TBL] [Abstract][Full Text] [Related]
19. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
Pittaluga A; Bonfanti A; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
[TBL] [Abstract][Full Text] [Related]
20. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
